Allied Healthcare Products (Allied Healthcare Products) ROCE % : -47.39% (As of Jun. 2022)

View and export this data going back to 1992. Start your Free Trial

What is Allied Healthcare Products ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Allied Healthcare Products's annualized ROCE % for the quarter that ended in Jun. 2022 was -47.39%.

Allied Healthcare Products ROCE % Historical Data

The historical data trend for Allied Healthcare Products's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Healthcare Products ROCE % Chart

Allied Healthcare Products Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

ROCE %

Get a 7-Day Free Trial

-13.23

-15.64

-27.21

17.59

-37.65

Allied Healthcare Products Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
ROCE %	Get a 7-Day Free Trial															67.15	-37.65	-49.46	-61.00	-47.39

Allied Healthcare Products ROCE % Calculation

Allied Healthcare Products's annualized ROCE % for the fiscal year that ended in Jun. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2022 )		(A: Jun. 2021 )		(A: Jun. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2022 )		(A: Jun. 2021 )		(A: Jun. 2022 )
	=	-4.57	/	( ( (17.702 - 7.114)	+	(19.671 - 5.982) )	/ 2 )
	=	-4.57	/	( (10.588	+	13.689)	/ 2 )
	=	-4.57	/	12.1385
	=	-37.65 %

Allied Healthcare Products's ROCE % of for the quarter that ended in Jun. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2022 )		(Q: Mar. 2022 )		(Q: Jun. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2022 )		(Q: Mar. 2022 )		(Q: Jun. 2022 )
	=	-5.064	/	( ( (16.151 - 8.467)	+	(19.671 - 5.982) )	/ 2 )
	=	-5.064	/	( ( 7.684	+	13.689 )	/ 2 )
	=	-5.064	/	10.6865
	=	-47.39 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2022) EBIT data.

Allied Healthcare Products (OTCPK:AHPIQ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Allied Healthcare Products ROCE % Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Allied Healthcare Products (Allied Healthcare Products) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1720 Sublette Avenue, Saint Louis, MO, USA, 63110

Website

https://www.alliedhpi.com

Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.

Executives

John D Weil	director, 10 percent owner	10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser	director	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa	officer: Vice President of Operations	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland	director, officer: President and CEO	1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus	officer: Vice President of Operations	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley	officer: VP of Operations	1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck	director	35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn	officer: VP - Finance and CFO	1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater	officer: VP - Administration	1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr	director	HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris	officer: Vice President of Operations	15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves	director	13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr	director	4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer	officer: VICE PRESIDENT SALES & MKTG	1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird	director	1350 ONE M&T PLAZA, BUFFALO NY 14203-2396